Featured Story

Pharma's Damaged Reputation

Can the industry fix its image problem?

PM1903 WebLeadImage 295X269

Say the words “Big Pharma” outside of the industry and images of life-saving drug discoveries rarely come to mind. Instead, the public perception of pharma is often shaped by issues like drug costs, prescription drug abuse, the supposed dangers of vaccines or corporate greed. One would think that when you’re in the business of saving lives, it would be easy to stay in the public’s good graces. But despite the good intentions of most pharma companies, the actions of a few bad actors continue to cast a cloud of mistrust over the entire industry. And pharma’s image in the public eye has suffered.In 2018, Gallup asked Americans to rate their perception of over a…

Full Story

Don't Miss These Pharma Manufacturing Exclusives

Fundamentals

On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Research Zone

A collection of news stories highlighting advances in medical science and pharmaceutical R&D.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • The Highest — and Lowest — Ranked Places to Work in Big Pharma

    By Meagan Parrish, Senior Editor

    If you want to really know what it’s like working at a company, checking out the employee reviews on Glassdoor, one of the world’s largest job sites, can often provide the answers. Although some of the comments — positive and negative — can seem extreme, Glassdoor has taken strides to…

    Full Story
  • Pharma's Rep: Redeeming the Seedy & Greedy

    By Karen Langhauser, Chief Content Director

    The burnout of the neon sign’s reputation has been dramatic.In the 1930s, neon was innovative and extravagant. During their hay day in the 1950s, glowing neon signs lit up the city skies, beckoned motorists off highways, and set businesses apart from competitors.But neon signs started becoming so…

    Full Story
  • Pharma's Damaged Reputation

    By Meagan Parrish, Senior Editor

    Say the words “Big Pharma” outside of the industry and images of life-saving drug discoveries rarely come to mind. Instead, the public perception of pharma is often shaped by issues like drug costs, prescription drug abuse, the supposed dangers of vaccines or corporate greed. One would think…

    Full Story
  • Generics Surge Forward

    By Karen Langhauser, Chief Content Director

    Chip Davis, Jr., President & CEO, Association for Accessible Medicines (right), welcomes Alex M. Azar II, U.S. Secretary of Health and Human Services to Access! 2019. In a historic first for the Association for Accessible Medicines annual meeting, Health and Human Services Secretary, Alex Azar,…

    Full Story
  • Preparing for the Upsurge in Pharma Cyber Attacks

    By Yoni Shohet, Co-founder and VP of Business Development, SCADAfence

    More and more manufacturing companies are joining the Industry 4.0 revolution by integrating their operational technology (OT) devices with external devices and systems, reaping the many benefits of automated and advanced manufacturing. The increasing connectivity of OT networks leads to a…

    Full Story
  • Excipients Fit for 21st Century Medicine

    By Joshua S. Katz, Abigail Nolin, Benjamin A. Yezer, and Susan Jordan, DuPont Nutrition and Health

    As biologics continue to expand in the marketplace, they present a unique array of challenges for producers compared to conventional small molecule drugs. The suite of functional excipients for biologics is limited in comparison to those used in small molecule oral drug delivery, further…

    Full Story

Latest Products